Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Identification of microbial and proteomic biomarkers in early childhood caries.

Hart TC, Corby PM, Hauskrecht M, Hee Ryu O, Pelikan R, Valko M, Oliveira MB, Hoehn GT, Bretz WA.

Int J Dent. 2011;2011:196721. doi: 10.1155/2011/196721. Epub 2011 Oct 16.

2.

Biomarker discovery in serum from patients with carotid atherosclerosis.

Degraba TJ, Hoehn GT, Nyquist PA, Wang H, Kenney R, Gonzales DA, Kern SJ, Ying SX, Munson PJ, Suffredini AF.

Cerebrovasc Dis Extra. 2011 Jan-Dec;1(1):115-29. doi: 10.1159/000334477. Epub 2011 Dec 3.

3.

Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease.

Tumblin A, Tailor A, Hoehn GT, Mack AK, Mendelsohn L, Freeman L, Xu X, Remaley AT, Munson PJ, Suffredini AF, Kato GJ.

Haematologica. 2010 Sep;95(9):1467-72. doi: 10.3324/haematol.2009.018044. Epub 2010 Apr 7.

4.

A novel peak detection approach with chemical noise removal using short-time FFT for prOTOF MS data.

Zhang S, Wang H, Zhou X, Hoehn GT, DeGraba TJ, Gonzales DA, Suffredini AF, Ching WK, Ng MK, Wong ST.

Proteomics. 2009 Aug;9(15):3833-42. doi: 10.1002/pmic.200800030.

5.

Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease.

Yuditskaya S, Tumblin A, Hoehn GT, Wang G, Drake SK, Xu X, Ying S, Chi AH, Remaley AT, Shen RF, Munson PJ, Suffredini AF, Kato GJ.

Blood. 2009 Jan 29;113(5):1122-8. doi: 10.1182/blood-2008-03-142604. Epub 2008 Nov 20.

6.

Quality control of serum albumin depletion for proteomic analysis.

Seam N, Gonzales DA, Kern SJ, Hortin GL, Hoehn GT, Suffredini AF.

Clin Chem. 2007 Nov;53(11):1915-20. Epub 2007 Sep 21.

7.

Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.

Imanguli MM, Atkinson JC, Harvey KE, Hoehn GT, Ryu OH, Wu T, Kingman A, Barrett AJ, Bishop MR, Childs RW, Fowler DH, Pavletic SZ, Hart TC.

Exp Hematol. 2007 Feb;35(2):184-92.

8.

Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins.

Hortin GL, Seam N, Hoehn GT.

Clin Chem. 2006 Dec;52(12):2258-64. Epub 2006 Oct 26.

9.
10.

Coelution of other proteins with albumin during size-exclusion HPLC: Implications for analysis of urinary albumin.

Sviridov D, Meilinger B, Drake SK, Hoehn GT, Hortin GL.

Clin Chem. 2006 Mar;52(3):389-97. Epub 2006 Jan 5.

11.

Proteomics.

Hoehn GT, Suffredini AF.

Crit Care Med. 2005 Dec;33(12 Suppl):S444-8. Review. No abstract available.

PMID:
16340417
12.

Human AML cells in NOD/SCID mice: engraftment potential and gene expression.

Lumkul R, Gorin NC, Malehorn MT, Hoehn GT, Zheng R, Baldwin B, Small D, Gore S, Smith D, Meltzer PS, Civin CI.

Leukemia. 2002 Sep;16(9):1818-26.

13.

The adapter protein CrkL associates with CD34.

Felschow DM, McVeigh ML, Hoehn GT, Civin CI, Fackler MJ.

Blood. 2001 Jun 15;97(12):3768-75.

14.

Characterization of the tyrosine kinase Tnk1 and its binding with phospholipase C-gamma1.

Felschow DM, Civin CI, Hoehn GT.

Biochem Biophys Res Commun. 2000 Jun 24;273(1):294-301.

PMID:
10873601
15.

Tnk1: a novel intracellular tyrosine kinase gene isolated from human umbilical cord blood CD34+/Lin-/CD38- stem/progenitor cells.

Hoehn GT, Stokland T, Amin S, Ramírez M, Hawkins AL, Griffin CA, Small D, Civin CI.

Oncogene. 1996 Feb 15;12(4):903-13.

PMID:
8632913
16.

Supplemental Content

Loading ...
Support Center